Navigating the nuances of the Canadian guideline's stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders
Canadian Medical Association journal (CMAJ), 2024-03, Vol.196 (10), p.E348-E348 [Peer Reviewed Journal]2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.150034-l
Full text available